With regard to this, it is worth noting that during SARS‐CoV-2 infection, the activation of complement component C3 exacerbates ARDS and deposits of C3‐C5 complements are abundant in lung biopsies from COVID‐19 patients (69). The gene discussed is C5; the disease is acute respiratory distress syndrome.